Dan Ollendorf is Director of Value Measurement and Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University. His research interests include expanding the use of health technology assessment in low- and middle-income economies, as well as refinement of value assessment tools in the US and other high-income settings. Prior to joining CEVR, Dan was Chief Scientific Officer for the Institute for Clinical and Economic Review (ICER) for over 10 years, where he was responsible for the conduct of assessments of the clinical effectiveness and economic value of high impact health care technologies as well as coordination of the broader health technology assessment process. His 30 years of experience also include work in the hospital, informatics, insurance, and consulting sectors.
Dan holds a Ph.D. in clinical epidemiology from the University of Amsterdam, a Master’s of Public Health from Boston University, and a Bachelor of Arts from the University of Rochester. Dan currently serves as a non-resident Fellow at the Center for Global Development, is a member of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) HTA Council Working Group, and is the Chair of the Health Technology Assessment International (HTAi) Global Policy Forum. From 2015-2019, he served on the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC).